Ultragenyx’s Angelman therapy fails Phase 3 trial in setback for company and patientsnews2026-09-03T01:35:17+00:00September 3rd, 2026|Endpoints News|
Mindray North America Celebrates Grand Opening of Expanded Mahwah Warehousenews2026-09-02T20:39:40+00:00September 2nd, 2026|Medical Device News Magazine|
Invivoscribe Begins Commercial Shipments of PrepQuant™ Systems, Enabling High-Sensitivity Sample Preparation for MRD Testingnews2026-09-02T19:50:01+00:00September 2nd, 2026|Medical Device News Magazine|
NATIONAL ATHLETIC TRAINERS’ ASSOCIATION RELEASES NEW COLLEGIATE ATHLETE MENTAL HEALTH GUIDELINESnews2026-09-02T19:40:57+00:00September 2nd, 2026|Medical Device News Magazine|
FDA leaders project enhanced scrutiny of foreign datanews2026-09-02T19:21:51+00:00September 2nd, 2026|Endpoints News|
Novartis CAR-T deaths raise questions over acceptable autoimmune risknews2026-09-02T18:48:44+00:00September 2nd, 2026|Endpoints News|
A Guide to Covid, Flu and R.S.V. Vaccines This Fallnews2026-09-02T17:07:44+00:00September 2nd, 2026|The New York Times|
Median Technologies Announces Formation of Strategic Review Committee and R&D Committee to Unlock Intrinsic Value and Accelerate Its eyonis® Pan-Cancer Strategynews2026-09-02T16:58:09+00:00September 2nd, 2026|Medical Device News Magazine|